These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8614641)

  • 21. Chemical probing studies of the hepatitis delta virus (HDV) genomic ribozyme.
    Nishikawa S; Kumar PK; Jeoung YH; Kawakami J; Nishikawa F; Suh Y; Ohtsuka E; Taira K
    Nucleic Acids Symp Ser; 1993; (29):119-20. PubMed ID: 8247731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energetic contribution of non-essential 5' sequence to catalysis in a hepatitis delta virus ribozyme.
    Shih Ih ; Been MD
    EMBO J; 2001 Sep; 20(17):4884-91. PubMed ID: 11532952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A toggle duplex in hepatitis delta virus self-cleaving RNA that stabilizes an inactive and a salt-dependent pro-active ribozyme conformation.
    Perrotta AT; Been MD
    J Mol Biol; 1998 Jun; 279(2):361-73. PubMed ID: 9642043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic and binding analysis of the catalytic involvement of ribose moieties of a trans-acting delta ribozyme.
    Fiola K; Perreault JP
    J Biol Chem; 2002 Jul; 277(29):26508-16. PubMed ID: 12015324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-D models of the antigenomic ribozyme of the hepatitis delta agent with eight new contacts suggested by sequence analysis of 188 cDNA clones.
    Branch AD; Polaskova JA
    Nucleic Acids Res; 1995 Oct; 23(20):4180-9. PubMed ID: 7479082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and NMR analysis of HDV ribozymes for structural investigation.
    Tanaka Y; Hori T; Katahira M; Nishikawa F; Sakamoto T; Fukunaga Y; Kurihara Y; Nishikawa S; Uesugi S
    Nucleic Acids Symp Ser; 1999; (42):221-2. PubMed ID: 10780459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mechanistic framework for co-transcriptional folding of the HDV genomic ribozyme in the presence of downstream sequence.
    Diegelman-Parente A; Bevilacqua PC
    J Mol Biol; 2002 Nov; 324(1):1-16. PubMed ID: 12421555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity correlation for an HDV ribozyme composed of three RNA strands.
    Tanaka Y; Sakamoto T; Sasa K; Kuwabara T; Kim MH; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Symp Ser; 1997; (37):309-10. PubMed ID: 9586123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of an extra substrate binding site and partial destabilization of stem structures in HDV ribozyme give rise to high sequence-specificity for its target RNA.
    Hori T; Guo F; Uesugi S
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):489-501. PubMed ID: 16838841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental evidence for the secondary structure of the hepatitis delta virus ribozyme.
    Perrotta AT; Rosenstein SP; Been MD
    Prog Clin Biol Res; 1993; 382():69-77. PubMed ID: 8502719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Core sequences and a cleavage site wobble pair required for HDV antigenomic ribozyme self-cleavage.
    Perrotta AT; Been MD
    Nucleic Acids Res; 1996 Apr; 24(7):1314-21. PubMed ID: 8614636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of an extruded nucleotide on cleavage activity and dynamic catalytic core conformation of the hepatitis delta virus ribozyme.
    Sefcikova J; Krasovska MV; Spacková N; Sponer J; Walter NG
    Biopolymers; 2007 Apr 5-15; 85(5-6):392-406. PubMed ID: 17253610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detailed analysis of base preferences at the cleavage site of a trans-acting HDV ribozyme: a mutation that changes cleavage site specificity.
    Nishikawa F; Fauzi H; Nishikawa S
    Nucleic Acids Res; 1997 Apr; 25(8):1605-10. PubMed ID: 9092669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of an active site Mg(2+) in HDV ribozyme self-cleavage: insights from QM/MM calculations.
    Mlýnský V; Walter NG; Šponer J; Otyepka M; Banáš P
    Phys Chem Chem Phys; 2015 Jan; 17(1):670-9. PubMed ID: 25412464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of the helix 2 region for the cis-cleaving and trans-cleaving activities of hepatitis delta virus ribozymes.
    Lee CB; Lai YC; Ping YH; Huang ZS; Lin JY; Wu HN
    Biochemistry; 1996 Sep; 35(38):12303-12. PubMed ID: 8823164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interaction between RNA molecules of a two-componet trans-analog of antigenomic HDV-ribozyme].
    Alekseenkova VA; Belianko TI; Lukin MA; Savochkina LP; Bibilashvili RSh
    Mol Biol (Mosk); 2006; 40(1):90-9. PubMed ID: 16523696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of antigenomic hepatitis delta virus ribozyme cis- and trans- analogs.
    Savochkina L; Alekseenkova V; Belyanko T; Lukin M; Beabealashvilli R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):935-42. PubMed ID: 15560085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping the interactions of selected antibiotics and their Cu2+ complexes with the antigenomic δ ribozyme.
    Wrzesinski J; Błaszczyk L; Wrońska M; Kasprowicz A; Stokowa-Sołtys K; Nagaj J; Szafraniec M; Kulinski T; Jeżowska-Bojczuk M; Ciesiołka J
    FEBS J; 2013 Jun; 280(11):2652-64. PubMed ID: 23527582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of a hepatitis delta virus ribozyme.
    Ferré-D'Amaré AR; Zhou K; Doudna JA
    Nature; 1998 Oct; 395(6702):567-74. PubMed ID: 9783582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.